Luminex receives $11.6 million DOD contract for biothreat detector

Luminex Corp., an Austin, Texas-based developer of biological test technology, has been awarded an $11.6 million contract from the U.S. Department of Defense to create a portable and flexible diagnostic instrument for rapid biothreat detection.

The contract for the development of the detector and response biomarkers indicative of systemic disease is meant to improve the military's ability to detect and defeat biological and chemical weapons, Military Aerospace reports.

The Luminex contract comes after an announcement from the U.S. Army Edgewood Chemical Biological Center was revised. The announcement called for funding for multiple related projects. The projects include an investigation of microbial systems, an investigation of self-decontaminating coatings that have biochemical or enzymatic compounds, the creation of enzymatic systems for the degradation of dangerous chemicals, and natural products used for the bioremediation of hazardous wastes like chemical agents and chemical warfare materials.

Each of the projects mentioned by the ECBC announcement are categorized as category A, which means they are high program priorities with a high funding probability.

Luminex Corp. will conduct the work for the $11.6 million contract at its headquarters in Austin. The company anticipates the development of the novel technology by January 2016, according to Military Aerospace.

The ECBC has full-time employees at three different U.S. sites including in the Edgewood Area of Aberdeen Proving Ground, Maryland, Pine Bluff, Arkansas and Rock Island, Illinois.

Organizations in this Story

U.S. Department of Defense

Want to get notified whenever we write about U.S. Department of Defense ?
Next time we write about U.S. Department of Defense, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.